We observed a slight decrease in T-ALL viability with CD3/CD28; however, the negative effect of NVP-BEP800 on the viability of T-ALL cells was antagonized after cross-linking of CD3/CD28 (Fig. 6c). The gene discussed is CD28; the disease is acute lymphoblastic leukemia.